Literature DB >> 17671779

Effect of activated protein C on pulmonary blood flow and cytokine production in experimental acute lung injury.

Jean-Christophe Richard1, Fabienne Bregeon, Véronique Leray, Didier Le Bars, Nicolas Costes, Christian Tourvieille, Franck Lavenne, Mojgan Devouassoux-Shisheboran, Gerard Gimenez, Claude Guerin.   

Abstract

OBJECTIVE: In acute lung injury (ALI) activated protein C (APC) may reopen occluded lung vessels and minimize lung inflammation. We aimed at assessing the effect of APC on regional lung perfusion, aerated lung volume, cytokine production and oxygenation in experimental ALI. DESIGN AND
SETTING: Prospective, controlled study in an imaging facility. PARTICIPANTS: Pigs tracheotomized and mechanically ventilated. INTERVENTION: Pigs were randomly given intravenously APC (n = 8) or saline (n = 8). Thirty minutes later, ALI was induced by injecting oleic acid. MEASUREMENTS AND
RESULTS: Lung perfusion and aerated lung volume measured with positron emission tomography, plasma cytokines and arterial blood gas were determined just before ALI and 110 and 290 min thereafter. Lung cytokines were measured at the end of the experiment. PaO2 under F I O2 1 was significantly lower in the APC group before lung injury (473+/-129 vs. 578+/-54 mmHg) and 110 min (342+/-138 vs. 446+/-103 mmHg) and 290 min (303+/-171 vs. 547+/-54 mmHg) thereafter (p < 0.05). Lung perfusion nonsignificantly tended to redistribute towards dorsal lung regions with APC. Total aerated lung volume was not different between APC and control before ALI (10.0+/-1.5 vs. 11.0+/-2.5 ml/kg) (p > 0.05) or thereafter. Plasma IL-6 and IL-8 at 110 min were greater with APC (p < 0.05).
CONCLUSIONS: In contrast to studies using other models, pretreatment with APC was associated with worsening oxygenation in the present investigation. This might be due to ventilation-perfusion mismatch, with more perfusion to dependent nonaerated areas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671779     DOI: 10.1007/s00134-007-0782-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  35 in total

1.  Mitigation of injury in canine lung grafts by exogenous surfactant therapy.

Authors:  R J Novick; A A Gilpin; K E Gehman; I S Ali; R A Veldhuizen; J Duplan; L Denning; F Possmayer; D Bjarneson; J F Lewis
Journal:  J Thorac Cardiovasc Surg       Date:  1997-02       Impact factor: 5.209

2.  Vascular components of ARDS. Clinical pulmonary hemodynamics and morphology.

Authors:  W M Zapol; R Jones
Journal:  Am Rev Respir Dis       Date:  1987-08

3.  Local abnormalities of coagulation and fibrinolysis and alveolar fibrin deposition in sheep with oleic acid-induced lung injury.

Authors:  S Idell; B T Peterson; K K Gonzalez; L D Gray; R Bach; J McLarty; D S Fair
Journal:  Am Rev Respir Dis       Date:  1988-11

Review 4.  ARDS: clinical lessons from the oleic acid model of acute lung injury.

Authors:  D P Schuster
Journal:  Am J Respir Crit Care Med       Date:  1994-01       Impact factor: 21.405

5.  Comparison of PET with radioactive microspheres to assess pulmonary blood flow.

Authors:  Jean-Christophe Richard; Marc Janier; Francois Decailliot; Didier Le Bars; Franck Lavenne; Veronique Berthier; Martine Lionnet; Luc Cinotti; Guy Annat; Claude Guérin
Journal:  J Nucl Med       Date:  2002-08       Impact factor: 10.057

6.  Effects of positive end-expiratory pressure and body position on pulmonary blood flow redistribution in mechanically ventilated normal pigs.

Authors:  Jean-Christophe Richard; Francois Decailliot; Marc Janier; Guy Annat; Claude Guérin
Journal:  Chest       Date:  2002-09       Impact factor: 9.410

7.  Pathogenesis of oleic acid-induced lung injury in the rat: distribution of oleic acid during injury and early endothelial cell changes.

Authors:  G Beilman
Journal:  Lipids       Date:  1995-09       Impact factor: 1.880

8.  Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats.

Authors:  K Murakami; K Okajima; M Uchiba; M Johno; T Nakagaki; H Okabe; K Takatsuki
Journal:  Blood       Date:  1996-01-15       Impact factor: 22.113

9.  Effect of position, nitric oxide, and almitrine on lung perfusion in a porcine model of acute lung injury.

Authors:  J C Richard; M Janier; F Lavenne; V Berthier; D Lebars; G Annat; F Decailliot; C Guerin
Journal:  J Appl Physiol (1985)       Date:  2002-08-30

10.  Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response.

Authors:  Laurent Robriquet; François Collet; Antoine Tournoys; Thierry Prangère; Rémi Nevière; François Fourrier; Benoît P Guery
Journal:  Respir Res       Date:  2006-03-22
View more
  9 in total

1.  Recombinant human activated protein C in experimental models of acute lung injury: the timing is critical!

Authors:  Corinna Velik-Salchner; Volker Wenzel; Dirk M Maybauer; Marc O Maybauer
Journal:  Intensive Care Med       Date:  2007-08-02       Impact factor: 17.440

2.  Aspirin for prevention of acute respiratory distress syndrome (ARDS): let's not throw the baby with the water!

Authors:  Mehdi Mezidi; Claude Guérin
Journal:  Ann Transl Med       Date:  2016-10

3.  Cytoprotective-selective activated protein C attenuates Pseudomonas aeruginosa-induced lung injury in mice.

Authors:  Nastasha Bir; Mathieu Lafargue; Marybeth Howard; Arnaud Goolaerts; Jeremie Roux; Michel Carles; Mitchell J Cohen; Karen E Iles; José A Fernández; John H Griffin; Jean-Francois Pittet
Journal:  Am J Respir Cell Mol Biol       Date:  2011-01-21       Impact factor: 6.914

Review 4.  Protective mechanisms of activated protein C in severe inflammatory disorders.

Authors:  Arne P Neyrinck; Kathleen D Liu; James P Howard; Michael A Matthay
Journal:  Br J Pharmacol       Date:  2009-05-14       Impact factor: 8.739

Review 5.  Year in review 2009: Critical Care--shock.

Authors:  Wolfgang Stahl; Hendrik Bracht; Peter Radermacher; Jörg Thomas
Journal:  Crit Care       Date:  2010-11-05       Impact factor: 9.097

Review 6.  Recombinant human activated protein C in acute lung injury: what is the role of bronchial circulation?

Authors:  Marc O Maybauer; Daniel L Traber; Dirk M Maybauer
Journal:  Crit Care       Date:  2009-01-23       Impact factor: 9.097

7.  Recombinant human activated protein C ameliorates oleic acid-induced lung injury in awake sheep.

Authors:  Kristine Waerhaug; Mikhail Y Kirov; Vsevolod V Kuzkov; Vladimir N Kuklin; Lars J Bjertnaes
Journal:  Crit Care       Date:  2008-11-20       Impact factor: 9.097

Review 8.  Year in review in Intensive Care Medicine, 2007. I. Experimental studies. Clinical studies: brain injury and neurology, renal failure and endocrinology.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2008-01-04       Impact factor: 17.440

9.  Effect of hypertonic saline treatment on the inflammatory response after hydrochloric acid-induced lung injury in pigs.

Authors:  Carla Augusto Holms; Denise Aya Otsuki; Marcia Kahvegian; Cristina Oliveira Massoco; Denise Tabacchi Fantoni; Paulo Sampaio Gutierrez; Jose Otavio Costa Auler Junior
Journal:  Clinics (Sao Paulo)       Date:  2015-08       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.